Personalized Ophthalmology Therapies Global Market Report 2025
상품코드:1855949
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
맞춤형 안과 치료 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 28억 2,000만 달러로 평가되었고, 2025년에는 32억 3,000만 달러에 달하고, CAGR 14.4%로 성장할 전망입니다. 역사적인 기간의 성장은 당뇨병 이환율 증가, 정부의 이니셔티브, 노화, 안과 의료에서 정밀의료에 대한 수요 증가, 안과 질환의 유병률 증가에 의해 초래되었습니다.
맞춤형 안과 치료 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 14.0%로 54억 6,000만 달러로 성장할 전망입니다. 예측기간의 성장을 뒷받침하는 것은 유전자검사와 분자진단의 이용 용이성 향상, 노화황반변성례 증가, 개별화의료에 대한 의식의 높아짐, 의료비 증가, 안과연구에 대한 투자의 확대입니다. 예측 기간 동안 예상되는 주요 동향으로는 생명 공학 기업, 연구 기관, 의료 제공업체 간의 전략적 제휴, 안과의 인공지능과 머신러닝의 전개, 유전체과 디지털 건강 기술의 통합, 유전자 치료 및 세포 치료의 급속한 진보, 고급 기술 솔루션의 채택 등이 있습니다.
만성적인 시력 장애의 유병률 증가는 맞춤형 안과 치료 시장의 확대를 촉진할 것으로 예측됩니다. 만성 시력 장애는 시력이 점차 감소하고 종종 지속적인 관리가 필요한 장기적인 안 질환입니다. 이러한 장애 증가는 당뇨병의 전반적인 이환율 증가와 밀접한 관련이 있으며, 당뇨병 망막증과 같은 합병증을 유발할 수 있습니다. 맞춤형 안과 치료는 개인의 유전적 및 분자적 프로파일을 기반으로 치료 계획을 조정함으로써 이러한 만성 질환을 치료하도록 설계되었습니다. 이 개인화 접근법은 치료 효과를 높이고 질병 진행을 늦추는 데 도움이 됩니다. 예를 들어, 2024년 5월 미국 정부보건기구인 질병대책예방센터는 효과적인 개입이 실시되지 않으면 당뇨병성 망막증 환자 수는 72% 증가하고 백내장 환자 수는 2050년까지 87% 증가할 것으로 예측했습니다. 이러한 동향은 안과에서의 맞춤형 치료에 대한 수요 증가를 뒷받침하고 있습니다.
맞춤형 안과 치료 시장의 주요 기업은 치료 빈도와 이에 따른 합병증을 줄이기 위해 단일 투여 유리체내 유전자 치료의 개발을 추진하고 있습니다. 이러한 치료법에서는 안구의 유리체강 내에 1회만 주사함으로써, 장애의 근본적인 원인을 타겟으로 하는 유전 물질을 전달하여, 치료 효과를 장기간 지속시킵니다. 예를 들어, 2025년 7월 프랑스에 본사를 두고 있는 제약 및 헬스케어 기업의 사노피는 연령 황반변성에 의한 지리적 위축의 치료를 목적으로 한 일회 투여의 유리체내 유전자 치료제 SAR446597에 대해 미국 식품의약품국으로부터 패스트트랙 지정을 받았습니다. 이 치료법은 고전적인 보체 시스템과 대체 보체 시스템의 구성요소를 억제하는 2개의 항체 단편을 코딩하는 유전 물질을 투여하는 것으로, 특히 C1s 및 Bb 인자를 표적으로 합니다. 이러한 경로를 억제함으로써, 이 치료는 망막에서 질병의 진행을 지연시키고 반복적으로 주사할 필요성을 감소시키는 것을 목표로 합니다. 빠른 트랙 지정은 제한된 치료 옵션을 가진 심각한 병리를 다루는 치료법 개발 및 규제 당국의 심사 과정을 가속화하는 것을 목표로합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 맞춤형 안과 치료 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 맞춤형 안과 치료 시장 : 성장률 분석
세계의 맞춤형 안과 치료 시장 실적: 규모와 성장, 2019년-2024년
세계의 맞춤형 안과 치료 시장 예측 : 규모와 성장, 2024년-2029년, 2034년
세계의 맞춤형 안과 치료 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 맞춤형 안과 치료 시장 : 치료 유형별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
유전자 치료
세포요법
파마코유전체학
타겟 약물전달
기타 치료 유형
세계의 맞춤형 안과 치료 시장 : 적응증별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
노화 황반 변성
당뇨병 망막증
녹내장
망막 색소 변성증
기타 적응증
세계의 맞춤형 안과 치료 시장 : 최종사용자별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
병원
전문 클리닉
연구기관
기타 최종 사용자
세계의 맞춤형 안과 치료 시장 : 세분화 유전자 치료, 유형별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
바이러스 벡터 기반 유전자 요법
비바이러스성 유전자요법
CRISPR 또는 Cas9 기반 유전자 편집
세계의 맞춤형 안과 치료 시장 : 세분화 세포 치료, 유형별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
줄기세포요법
망막 색소 상피(RPE) 세포 요법
인공 다능성 줄기세포(iPSC) 요법
세계의 맞춤형 안과 치료 시장 : 세분화 파마코유전체학, 유형별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
약물 반응 검사
유전자 바이오마커에 기초한 요법
개별화 약물 투여
세계의 맞춤형 안과 치료 시장 : 세분화 표적 약물전달, 유형별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
나노 입자 기반의 전달
리포좀 약물전달
하이드로겔 기반의 전달 시스템
세계의 맞춤형 안과 치료 시장 : 세분화 기타 치료 유형, 유형별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
RNA 기반 요법
안티센스 올리고뉴클레오티드 요법
펩티드 기반 요법
제7장 지역별/국가별 분석
세계의 맞춤형 안과 치료 시장 : 지역별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
세계의 맞춤형 안과 치료 시장 : 국가별, 분석과 예측, 2019년-2024년, 2024년-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
맞춤형 안과 치료 시장 : 경쟁 구도
맞춤형 안과 치료 시장 : 기업 프로파일
Roche Holding AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Novartis AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Regeneron Pharmaceuticals Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Alcon Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Genentech Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Bausch Lomb Corporation
Johnson & Johnson Vision Care Inc.
Carl Zeiss Meditec AG
Santen Pharmaceutical Co. Ltd.
Ocular Therapeutix Inc.
EyePoint Pharmaceuticals Inc.
Senju Pharmaceutical Co. Ltd.
MeiraGTx Ltd.
Beacon Therapeutics
Clearside Biomedical Inc.
Adverum Biotechnologies Inc.
Ocugen Inc.
GenSight Biologics
Nanoscope Therapeutics Inc.
4D Molecular Therapeutics Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
맞춤형 안과 치료 시장 2029년 : 새로운 기회를 제공하는 국가
맞춤형 안과 치료 시장 2029년 : 새로운 기회를 제공하는 부문
맞춤형 안과 치료 시장 2029년 : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
SHW
영문 목차
영문목차
Personalized ophthalmology therapies are customized treatment approaches for eye diseases and vision disorders that are tailored to an individual patient's genetic profile, molecular characteristics, lifestyle, and clinical condition. These therapies utilize advances in genomics, biomarker analysis, imaging, and precision medicine to optimize drug selection, dosage, or surgical interventions for conditions such as age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, and inherited retinal diseases.
The primary types of personalized ophthalmology therapies include gene therapy, cell therapy, pharmacogenomics, targeted drug delivery, and others. Gene therapy involves introducing or modifying genetic material within a patient's cells to treat eye diseases caused by genetic mutations. These therapies are applied for various indications including AMD, diabetic retinopathy, glaucoma, and retinitis pigmentosa, and are used by hospitals, specialty clinics, research institutes, and other healthcare organizations.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The personalized ophthalmology therapies market research report is one of a series of new reports from The Business Research Company that provides personalized ophthalmology therapies market statistics, including personalized ophthalmology therapies industry global market size, regional shares, competitors with a personalized ophthalmology therapies market share, detailed personalized ophthalmology therapies market segments, market trends and opportunities, and any further data you may need to thrive in the personalized ophthalmology therapies industry. This personalized ophthalmology therapies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The personalized ophthalmology therapies market size has grown rapidly in recent years. It will grow from $2.82 billion in 2024 to $3.23 billion in 2025 at a compound annual growth rate (CAGR) of 14.4%. Growth in the historic period was driven by rising rates of diabetes, government initiatives, an aging population, growing demand for precision medicine in eye care, and increasing prevalence of ophthalmic diseases.
The personalized ophthalmology therapies market size is expected to see rapid growth in the next few years. It will grow to $5.46 billion in 2029 at a compound annual growth rate (CAGR) of 14.0%. Growth in the forecast period is expected to be supported by greater accessibility of genetic testing and molecular diagnostics, increasing cases of age-related macular degeneration, rising awareness of personalized medicine, higher healthcare expenditure, and growing investment in ophthalmic research. Key trends anticipated for the forecast period include strategic collaborations between biotechnology firms, research institutes, and healthcare providers, deployment of artificial intelligence and machine learning in ophthalmology, integration of genomics with digital health technologies, rapid advancements in genetic and cellular therapies, and adoption of advanced technological solutions.
The growing prevalence of chronic vision disorders is expected to drive the expansion of the personalized ophthalmology therapies market. Chronic vision disorders are long-term eye conditions that progressively impair vision and often require continuous management. The rise in these disorders is closely linked to the increasing global incidence of diabetes, which can lead to complications such as diabetic retinopathy-a condition that gradually damages the retina over time. Personalized ophthalmology therapies are designed to address such chronic disorders by tailoring treatment plans based on an individual's genetic and molecular profile. This personalized approach enhances treatment effectiveness and helps slow disease progression. For example, in May 2024, the Centers for Disease Control and Prevention, a government health agency in the United States, projected that if effective interventions are not implemented, the number of diabetic retinopathy cases will increase by 72 percent, while cataract cases are expected to grow by 87 percent by the year 2050. These trends underscore the growing demand for individualized treatments in ophthalmology.
Leading companies in the personalized ophthalmology therapies market are advancing the development of single-dose intravitreal gene therapies to reduce the frequency of treatments and associated complications. These therapies involve a one-time injection into the vitreous cavity of the eye to deliver genetic material that targets the underlying cause of the disorder, providing long-lasting therapeutic effects. For instance, in July 2025, Sanofi, a pharmaceutical and healthcare company based in France, received fast track designation from the United States Food and Drug Administration for SAR446597, a single-dose intravitreal gene therapy aimed at treating geographic atrophy caused by age-related macular degeneration. This therapy delivers genetic material that encodes two antibody fragments which inhibit components of the classical and alternative complement pathways, specifically targeting C1s and factor Bb. By suppressing these pathways, the treatment aims to slow disease progression in the retina and reduce the need for repeated injections. The fast track designation is intended to accelerate the development and regulatory review process for therapies that address serious medical conditions with limited treatment options.
In June 2022, Novartis, a pharmaceutical company headquartered in Switzerland, acquired Kedalion Therapeutics for an undisclosed amount. This acquisition enables Novartis to expand its capabilities in precision ocular drug delivery technologies. Kedalion Therapeutics has developed innovative approaches to enhance the administration and effectiveness of eye treatments while improving patient comfort. The acquisition aligns with Novartis' strategic focus on delivering patient-centric, personalized solutions for a broad range of eye conditions and reinforces its position in the ophthalmology market.
Major players in the personalized ophthalmology therapies market are Roche Holding AG, Novartis AG, Regeneron Pharmaceuticals Inc., Alcon Inc., Genentech Inc., Bausch + Lomb Corporation, Johnson & Johnson Vision Care Inc., Carl Zeiss Meditec AG, Santen Pharmaceutical Co. Ltd., Ocular Therapeutix Inc., EyePoint Pharmaceuticals Inc., Senju Pharmaceutical Co. Ltd., MeiraGTx Ltd., Beacon Therapeutics, Clearside Biomedical Inc., Adverum Biotechnologies Inc., Ocugen Inc., GenSight Biologics, Nanoscope Therapeutics Inc., 4D Molecular Therapeutics Inc., Coave Therapeutics.
North America was the largest region in the personalized ophthalmology therapies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in personalized ophthalmology therapies report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the personalized ophthalmology therapies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The personalized ophthalmology therapies market includes revenues earned by entities by providing services such as molecular profiling, biomarker identification, patient data integration services, and disease risk assessment. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Personalized Ophthalmology Therapies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on personalized ophthalmology therapies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for personalized ophthalmology therapies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The personalized ophthalmology therapies market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Therapy Type: Gene Therapy; Cell Therapy; Pharmacogenomics; Targeted Drug Delivery; Other Therapy Types
2) By Indication: Age-Related Macular Degeneration; Diabetic Retinopathy; Glaucoma; Retinitis Pigmentosa; Other Indications
3) By End User: Hospitals; Specialty Clinics; Research Institutes; Other End Users
Subsegments:
1) By Gene Therapy: Viral Vector-Based Gene Therapy; Non-Viral Gene Therapy; CRISPR Or Cas9-Based Gene Editing
3. Personalized Ophthalmology Therapies Market Trends And Strategies
4. Personalized Ophthalmology Therapies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Personalized Ophthalmology Therapies Growth Analysis And Strategic Analysis Framework
5.1. Global Personalized Ophthalmology Therapies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Personalized Ophthalmology Therapies Market Growth Rate Analysis
5.4. Global Personalized Ophthalmology Therapies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Personalized Ophthalmology Therapies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Personalized Ophthalmology Therapies Total Addressable Market (TAM)
6.1. Global Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gene Therapy
Cell Therapy
Pharmacogenomics
Targeted Drug Delivery
Other Therapy Types
6.2. Global Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Age-Related Macular Degeneration
Diabetic Retinopathy
Glaucoma
Retinitis Pigmentosa
Other Indications
6.3. Global Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Research Institutes
Other End Users
6.4. Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Viral Vector-Based Gene Therapy
Non-Viral Gene Therapy
CRISPR Or Cas9-Based Gene Editing
6.5. Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Cell Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Stem Cell Therapy
Retinal Pigment Epithelial (RPE) Cell Therapy
Induced Pluripotent Stem Cell (iPSC) Therapy
6.6. Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Pharmacogenomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Response Testing
Genetic Biomarker-Based Therapy
Personalized Drug Dosing
6.7. Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Targeted Drug Delivery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nanoparticle-Based Delivery
Liposomal Drug Delivery
Hydrogel-Based Delivery Systems
6.8. Global Personalized Ophthalmology Therapies Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
RNA-Based Therapy
Antisense Oligonucleotide Therapy
Peptide-Based Therapy
7. Personalized Ophthalmology Therapies Market Regional And Country Analysis
7.1. Global Personalized Ophthalmology Therapies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Personalized Ophthalmology Therapies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Personalized Ophthalmology Therapies Market
9.1. China Personalized Ophthalmology Therapies Market Overview
9.2. China Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Personalized Ophthalmology Therapies Market
10.1. India Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Personalized Ophthalmology Therapies Market
11.1. Japan Personalized Ophthalmology Therapies Market Overview
11.2. Japan Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Personalized Ophthalmology Therapies Market
12.1. Australia Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Personalized Ophthalmology Therapies Market
13.1. Indonesia Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Personalized Ophthalmology Therapies Market
14.1. South Korea Personalized Ophthalmology Therapies Market Overview
14.2. South Korea Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Personalized Ophthalmology Therapies Market
15.1. Western Europe Personalized Ophthalmology Therapies Market Overview
15.2. Western Europe Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Personalized Ophthalmology Therapies Market
16.1. UK Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.1. Spain Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Personalized Ophthalmology Therapies Market
21.1. Eastern Europe Personalized Ophthalmology Therapies Market Overview
21.2. Eastern Europe Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Personalized Ophthalmology Therapies Market
22.1. Russia Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Personalized Ophthalmology Therapies Market
23.1. North America Personalized Ophthalmology Therapies Market Overview
23.2. North America Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Personalized Ophthalmology Therapies Market
24.1. USA Personalized Ophthalmology Therapies Market Overview
24.2. USA Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Personalized Ophthalmology Therapies Market
26.1. South America Personalized Ophthalmology Therapies Market Overview
26.2. South America Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Personalized Ophthalmology Therapies Market
27.1. Brazil Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Personalized Ophthalmology Therapies Market
28.1. Middle East Personalized Ophthalmology Therapies Market Overview
28.2. Middle East Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Personalized Ophthalmology Therapies Market
29.1. Africa Personalized Ophthalmology Therapies Market Overview
29.2. Africa Personalized Ophthalmology Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Personalized Ophthalmology Therapies Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Personalized Ophthalmology Therapies Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Personalized Ophthalmology Therapies Market Competitive Landscape And Company Profiles
